#

2nd World Summit on Vaccines Research and Development

November 17-19, 2025 London, UK


Abstract Submission Deadline: September 15, 2025

EarlyBird Registration Deadline: 20-03-2025

Welcome Message

  • Dear Colleagues,

    It is my pleasure to cordially invite you all to join the “2nd World Summit on Vaccines Research and Development (WSVRD-2025)” which will be held in London, United Kingdom during November 17-19, 2025.

    WSVRD-2025 is the ideal opportunity for research scientists, academics, leading experts and students working on Vaccines Research and Development to discuss their cutting-edge innovations, ideas and recent achievements. The meeting will cover both Vaccines Research and Development, COVID-19 vaccines, viral vector vaccines, genetic vaccines, HIV & AIDS vaccines, cancer vaccines, vaccines safety, Vaccine process development & production and other topics.

    WSVRD-2025 will be a three-day event that gathers together key players of the Vaccines Research and Development and related sectors. This event aims to attract global participant’s intent on sharing, exchanging and exploring new avenues of Vaccines Research and Development related scientific and commercial developments.

    The wide-ranging scientific program will consist of plenary lectures, keynote lectures, invited lectures, parallel sessions, as well as poster sessions for young scientists covering all topics in Vaccines Research and Development. This conference provides a wonderful opportunity for you to enhance your knowledge about the newest interdisciplinary approaches in Vaccines Research and Development. Moreover, the conference offers a valuable platform to create new contacts in the field of Vaccines Research and Development, by providing valuable networking time for you to meet great personnel in the field.

    We look forward to seeing you at WSVRD-2025 in London, United Kingdom.

    Sincerely,

    Philip M Arlen
    Conference chair | WSVRD-2025
    CEO and Founder, Precision Biologics, USA

Session

Rabies Vaccine

attenuated vaccines

Inactivated vaccines

Toxoid vaccines

Subunit, recombinant, polysaccharide, and conjugate vaccines

Polio Vaccines

Viral vector vaccines

COVID-19 vaccines

Hepatitis Immunology & Vaccine Biology

Malaria vaccines

Next-Generation Vaccine Delivery Technologies

Fungal/Bacterial/Viral/Parasitic/STD vaccines

Vaccines Safety, Efficacy & Regulatory affairs

Infectious and Non-Infectious Diseases

HIV&AIDS Vaccines

Thermo Stabilized Vaccines

cancer immunology and anti-tumor immunity

Diabetes Vaccines

Cancer Vaccines

Influenza and Respiratory Vaccines

veterinary vaccines

Therapeutic vaccination for Auto Immune Diseases

Genetic vaccine

Vaccines for Vector-borne Diseases

Cholera vaccine

Tuberculosis vaccine

Typhoid vaccine

Vaccine Production, Supply & Logistics

Smallpox vaccine

Influenza Vaccine

SARS vaccine

Emerging and Re-Emerging Diseases

Antimicrobial Resistance (AMR)

Immune Profiling

Clinical Trails

 

Registration


Keynote Session I


Refreshment Break


Keynote Session II


Lunch with Table Discussions


Break Out Session I


Refreshment Break


Breakout Session II

 

Keynote Session III


Refreshment Break


Break Out Session III


Lunch with Table Discussions


Poster Presentations


Refreshment Break


Breakout Session IV

 

Keynote Session IV


Refreshment Break


Break Out Session V


Lunch with Table Discussions


Poster Presentations


Refreshment Break


Breakout Session VI


EndNote Session and Closing Ceremony

Contact us

Scientific Summits
Follow Us on: